| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/04/1997 | EP0776363A1 Ribozyme library, its production and use |
| 06/04/1997 | EP0776361A1 Recombinant herpesvirus of turkeys and uses thereof |
| 06/04/1997 | EP0776359A1 Regulated apoptosis |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776335A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776224A1 Particle delivery |
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
| 06/04/1997 | EP0776160A1 Use of saponin for pathogen control |
| 06/04/1997 | EP0776159A1 Repellent compositions containing flavonoid aldehydes |
| 06/04/1997 | EP0751998A4 A gene expression system utilizing an rna polymerase prebound to dna |
| 06/04/1997 | EP0695359B1 A method for enhancing the production of biologically active recombinant proteins |
| 06/04/1997 | EP0691980B1 7-deazapurine modified oligonucleotides |
| 06/04/1997 | EP0690911A4 Stromelysin-1 deficient transgenic mice |
| 06/04/1997 | EP0680607A4 Assay method to rule out rupture of membranes in women at risk for imminent delivery. |
| 06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
| 06/04/1997 | EP0666903A4 Insulin-dependent yeast or fungi. |
| 06/04/1997 | EP0575387B1 Extraction system |
| 06/04/1997 | EP0545999B1 Process for the preparation of biologically active IGF-1 using IGF-1 having an amino-terminal extension |
| 06/04/1997 | EP0470230B1 Method for obtaining and purifying the carboxyl-terminal fragment of the dna polymerase i of streptococcus pneunomiae |
| 06/04/1997 | EP0411018B1 Detection, quantitation and classification of ras proteins in body fluids and tissues |
| 06/04/1997 | CN1151187A Subtilisin 309 variants having decreased absorption and increased hydrolysis |
| 06/04/1997 | CN1151186A Thymidine kinase mutants |
| 06/04/1997 | CN1151185A Nucleotide sequences of pestivirus strains, polypeptides encoded by these squences and use thereof for diagnosis and prevention of pestivirus infections |
| 06/04/1997 | CN1151184A Human Monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 06/04/1997 | CN1151183A RPS 2 gene and uses thereof |
| 06/04/1997 | CN1151120A Method and compositions useful for inhibition of angiogenesis |
| 06/03/1997 | US5635618 Expression construct conferring root specific expresssion in plants comprising regulatory sequence of maize alpha-tubulin consisting of specified nucleotides |
| 06/03/1997 | US5635617 Methods and compositions comprising the agfA gene for detection of Salmonella |
| 06/03/1997 | US5635615 High affinity HIV nucleocapsid nucleic acid ligands |
| 06/03/1997 | US5635604 Amino-terminally extended human growth hormone (HGH) |
| 06/03/1997 | US5635603 Antibody fragment covalently bound to diagnostic or therapeutic principle through carbohydrate moiety |
| 06/03/1997 | US5635601 Beta-8 integrin subunit antibodies |
| 06/03/1997 | US5635599 Circularly permuted il4, il2, granulocyte macrophage colony stimulating factor or granulocyte colony stimulating factor fused to a cytotoxin, i.e., pseudomonas exotoxin, diphtheria toxin without the native receptor-binding domain; cancer |
| 06/03/1997 | US5635594 Gallinacins - antibiotic peptides |
| 06/03/1997 | US5635488 Suited as diagnostics, therapeutics and research agents |
| 06/03/1997 | US5635480 Bacillus thuringiensis isolates and toxins |
| 06/03/1997 | US5635475 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 06/03/1997 | US5635400 Minimally cross-hybridizing sets of oligonucleotide tags |
| 06/03/1997 | US5635399 Retroviral vectors expressing cytokines |
| 06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
| 06/03/1997 | US5635386 Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
| 06/03/1997 | US5635385 Multi-unit ribozyme inhibition of oncogene gene expression |
| 06/03/1997 | US5635384 Comprising internal peptide linker sequence by removing the linker, splitting the protein, changing to active form |
| 06/03/1997 | US5635383 Delivering complex of polynucleotide and carrier comprising polycationic binding agent and ligand specific for cell receptor to cell wherein polynucleotide is released from carrier on entry into cell |
| 06/03/1997 | US5635382 Method for enhancing transmembrane transport of exogenous molecules |
| 06/03/1997 | US5635381 Genetically engineered cells having a dna sequence which codes a cyclic adenosine monophosphate recombinase and another sequence which controls its expression |
| 06/03/1997 | US5635380 Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids |
| 06/03/1997 | US5635378 Variant-type carbohydrate hydrolase, variant gene of the enzyme and method for producing oligosaccharide using the enzyme |
| 06/03/1997 | US5635377 Hybridizing complementary nucleotide sequences having a mixed phosphate backbone; activation of rnase h; cleavage |
| 06/03/1997 | US5635376 Method for purifying chromosomes and hybrid muntjac cell lines containing foreign chromosomes |
| 06/03/1997 | US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding |
| 06/03/1997 | US5635373 Bone morphogenic protein-5(BMP-5) and DNA encoding same |
| 06/03/1997 | US5635372 BMP-15 compositions |
| 06/03/1997 | US5635371 Modifying dna sequence encoding recombinant polypeptide by adding sequence encoding protecting group having cleavage sequence, removing biologically added protecting group, modifying unprotected terminal amino acid, deprotecting |
| 06/03/1997 | US5635370 DNA encoding BEHAB, a brain hyaluronan-binding protein, and recombinant expression systems for production of BEHAB polypeptides |
| 06/03/1997 | US5635369 Yeast strains with stable integration of heterologous genes |
| 06/03/1997 | US5635363 Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
| 06/03/1997 | US5635359 Method for measuring the activity of angiotensin converting enzyme in biological samples |
| 06/03/1997 | US5635355 Methods of obtaining a DNA sequence for integration site independent gene expression |
| 06/03/1997 | US5635352 Solution phase nucleic acid sandwich assays having reduced background noise |
| 06/03/1997 | US5635349 High-throughput screening assay for inhibitors of nucleic acid polymerases |
| 06/03/1997 | US5635345 Isolation of lymphocytes, incubation with labeled monoclonal antibody to a prosomal protein, measuring percentage of cells having this protein on cell surface, comparison with non-infected cells, human immunodeficiency virus, kits |
| 06/03/1997 | US5635182 Method of detecting ligand interactions |
| 06/03/1997 | US5635181 Pure immunogenic peptide encoded by dna sequence present in specified recombinant bacterial plasmid |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | US5635175 Treatment of herpes and cytomegalo viruses |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 05/30/1997 | CA2191503A1 Actinomycete promoter |
| 05/29/1997 | WO1997019357A1 Assay for blood clotting factors viii and ix |
| 05/29/1997 | WO1997019354A1 Storage-stable particle, in particular carrier for carrier-bound reactions, and methods of producing said particle |
| 05/29/1997 | WO1997019195A1 Amplification of nucleic acids and detection of a new non-a, non-b, non-c, non-d, non-e hepatitis virus |
| 05/29/1997 | WO1997019194A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
| 05/29/1997 | WO1997019193A2 Unimolecular segment amplification and detection |
| 05/29/1997 | WO1997019191A1 Method for detection of ki-ras mutations and kit to perform it |
| 05/29/1997 | WO1997019184A1 Liposomal transfection method |
| 05/29/1997 | WO1997019183A2 Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer |
| 05/29/1997 | WO1997019182A1 Production of retroviral vectors using herpes vectors |
| 05/29/1997 | WO1997019181A2 Virus vector for the transfer of stable episomes |
| 05/29/1997 | WO1997019180A2 Vector consisting of a transcriptional regulatory dna sequence linked to a dna sequence encoding beta-lactamase for enzyme prodrug therapy |
| 05/29/1997 | WO1997019179A1 Pseudomonas exotoxin - myelin basic protein chimeric proteins |
| 05/29/1997 | WO1997019178A2 Autoantigenic metal proteases and methods of diagnosing autoimmune diseases |
| 05/29/1997 | WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
| 05/29/1997 | WO1997019176A1 Malathion carboxylesterase |
| 05/29/1997 | WO1997019175A1 Improved microbial production of indigo |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019173A1 Method of treating sepsis |
| 05/29/1997 | WO1997019172A1 Differentiation-suppressive polypeptide |
| 05/29/1997 | WO1997019171A1 Epithelial membrane protein-1 |
| 05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
| 05/29/1997 | WO1997019167A1 Nucleic acid molecule encoding a 11-cis retinol dehydrogenase |
| 05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 05/29/1997 | WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997019109A1 Trypsin inhibitor protein from pentaclethra macroloba having insecticidal properties |
| 05/29/1997 | WO1997019100A1 N-1-carboxyalkyl derivatives of lsd |